SelectQuote, Inc. (SLQT)
Financials · Digital Insurance Marketplace & Distribution · NYSE
SelectQuote connects individual insurance shoppers and pharmacy customers to a marketplace of insurance carriers and pharmacies while earning commissions and generating margin-rich pharmacy retail revenue.
What SelectQuote, Inc. does
SelectQuote operates a digital marketplace that helps individual insurance consumers compare and purchase life, auto, home, and health insurance policies. The company earns commissions from insurance carriers for directing qualified leads and customer enrollments. Additionally, SelectQuote runs a pharmacy business that provides discounted prescription medications and other pharmaceutical products to consumers, generating revenue through direct retail sales and third-party network relationships.
Themes: insurance marketplace / lead generation, digital insurance comparison and enrollment, pharmacy retail and discounted medications, life and property-casualty insurance distribution, Heavy reliance on insurance commissions from carriers, which may be subject to competitive pressure, policy reform, or carrier relationship changes, Significant accumulated deficit and preferred stock liabilities ($408.4M liquidation preference as of March 2026) limiting financial flexibility and equity upside, Pharmacy business subject to cost-of-goods fluctuations, regulatory pressures on drug pricing, and competition from established pharmacy retailers and mail-order services, eHealth (EHTH), Policygenius, The Zebra
Fundamentals
- Price$0.55 as of 2026-08-26 close
- Market cap$97M as of 2026-08-26
- 1-year return-78.1% 2025-08-26 close $2.51 → 2026-08-26 close $0.55
- P/E1.15 as of 2026-08-26
- Net margin+5.6% as of 2026-08-26
- Gross margin+35.1% as of 2026-08-26
- ROE+15.3% as of 2026-08-26
- Debt / equity0.57 as of 2026-08-26
- Revenue growth (YoY)+10.3% as of 2026-08-26
- Revenue CAGR (3y)+26.0% SEC XBRL
- Beta1.63 as of 2026-08-26
- Last reported earnings2026-08-25 SEC EDGAR Form 8-K (Item 2.02)
Dividend: at least 3 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How SLQT compares in its sector
- price-to-earnings ratiobottom 10% 523 covered Financials peers, as of 2026-08-26
- net profit marginbottom 25% 538 covered Financials peers, as of 2026-08-26
- operating marginbottom 25% 534 covered Financials peers, as of 2026-08-26
- gross marginbottom 25% 176 covered Financials peers, as of 2026-08-26
- return on equitymiddle range 575 covered Financials peers, as of 2026-08-26
- 3-year revenue CAGRtop 25% 347 covered Financials peers
- free cash flow (absolute dollars, latest fiscal year)bottom 10% 431 covered Financials peers, as of FY2025
Position among covered Financials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage
Not assessed — last reported dividend predates the accounts. The most recent fiscal year in which SLQT reported a dividend payment is FY2020, while its reported financial statements run through FY2025. Coverage is therefore not assessed for the latest year — an FY2020 ratio would not describe SLQT today.
Coverage is derived from reported SEC EDGAR XBRL figures, comparing dividends paid against net income and free cash flow for the SAME fiscal year. It is not shown here because the latest fiscal year with a reported dividend payment (FY2020) is older than the latest year of reported financial statements (FY2025), so any ratio would describe an out-of-date year. Informational only — not financial advice.
How SelectQuote, Inc. looks technically
SelectQuote, Inc. (SLQT) is trading 47.3% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 319 trading days ago — a "death cross", a bearish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 18, below the 25 that marks a real trend), though sellers have been pushing harder than buyers lately — pressure, not a trend. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 32, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 2 trading days ago (its momentum flipped negative). It made a new 20-day low about 2 trading days ago. It is 80.1% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 47.3% below its 200-day average, the long-term trend line — a long-term downtrend | -47.3% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $0.7666 | $0.7666 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $1.04 | $1.04 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing low 14 calendar days ago — the swings before that are what the structure reading is measured on | 14 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that downward direction; the labelling fails if price closes above 0.635. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible downward five-wave sequence, in wave 4 (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 319 trading days ago — a "death cross", a bearish long-term signal | 319 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 18, below the 25 that marks a real trend), though sellers have been pushing harder than buyers lately — pressure, not a trend | 18.4 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 32, neither overbought (above 70) nor oversold (below 30) | 32.2 |
|---|---|---|
| Position in its 14-day range | it is trading near the bottom of its 14-day range ($0.482 to $0.895) — its "stochastic" reading is 16 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 16.5 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 2 trading days ago (its momentum flipped negative) | 2 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $2.77 | $2.77 |
|---|---|---|
| From the 52-week high | it is 80.1% below its 52-week high (its highest price of the past year) | -80.1% |
| Above the 52-week low | it is 14.1% above its 52-week low (its lowest price of the past year) | +14.1% |
| Below the 52-week high | it is 80.1% below its highest point of the past year | 80.1% |
| Since a 20-day breakout | it made a new 20-day low about 2 trading days ago | 2 sessions |
| Since a 55-day breakout | it made a new 55-day low about 2 trading days ago | 2 sessions |
| All-time high | its highest closing price on record is $33.00 (set on 2021-04-13) | $33.00 |
| Given back of the 52-week move | over the past year its closes ranged ($0.548 to $2.69), and it has recovered essentially none of its fall from last year’s high — 0% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $1.87 to $1.94. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 0.1% |
| From the all-time high | it is 98.3% below its all-time high | -98.3% |
| Nearest price level | it is trading 46.4% below a resistance level at $0.805 — a price it turned at twice since 2026-05-04, most recently on 2026-08-03. Since 2024-08-26 it has 0 such levels below the current price and 12 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +46.4% |
| All-time low | its lowest closing price on record is $0.482 (set on 2026-08-25) | $0.482 |
| Above the all-time low | it is 14.1% above its all-time low | +14.1% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 57th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.0785 between its high and its low — about 14.3% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.0785 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $0.58 and $0.86 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $0.58 – $0.72 – $0.86 |
| Typical daily range (% of price) | its price moves about 14.3% in a typical session — among the most volatile in the catalog. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 14.3% |
| Stretch from the 200-day average | it is trading 6.3 daily ranges below its 200-day average price (47.3% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 6.3 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.31× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
2
| Since a doji | 9 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 9 sessions ago |
|---|---|---|
| Since a bullish engulfing | 6 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 6 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-08-26 6.4% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +6.4% |
|---|---|---|
| Open gap | it gapped 16.4% below the previous close 1 session ago and has not traded back through the level it left behind at 0.78 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -16.4% |
| Gap filled | a 6.4% gap up opened on 2026-08-26 has been "filled" today — price traded back through the level the gap left behind, and it closed again during the very session that opened it | today |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 18.4 percentage points (the stock lost 14.7% while the market gained 3.7%) | -18.4% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 47.6 percentage points (the stock lost 45.5% while the market gained 2.1%) | -47.6% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 51.9 percentage points (the stock lost 40.7% while the market gained 11.1%) | -51.9% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 96.8 percentage points (the stock lost 78.1% while the market gained 18.7%) | -96.8% |
Signal agreement
2
| Bullish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bullish state: near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 1 of 9 |
|---|---|---|
| Bearish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, a fresh 20-day low, MACD momentum is negative, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 33% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-21 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thick, spanning 41.1% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | -32.8% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 43% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $0.962 — a volume-weighted average of daily closes over 158 sessions, not a true tick-by-tick VWAP. | -42.8% |
|---|---|---|
| Vs the average paid since it last reported | the price is 41% below the average price paid since it last reported on 2026-05-05 (its 10-Q), so the typical buyer over that stretch is under water. That average is $0.9376 — a volume-weighted average of daily closes over 76 sessions, not a true tick-by-tick VWAP. | -41.3% |
Price levels it has turned at before
SLQT last closed at $0.55 on 2026-08-26. Since 2024-08-26 it has turned at 0 prices below its last close and 12 above; the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $0.805 | Resistance | 46.4% above the last close | turned there twice · 2026-05-04 to 2026-08-03 |
| $0.944 | Resistance | 71.6% above the last close | turned there twice · 2026-02-20 to 2026-05-26 |
| $1.33 | Resistance | 142.7% above the last close | turned there twice · 2025-11-20 to 2026-01-08 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes above $0.635.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
On past moves of this shape the leg has usually ended somewhere between $0.635 and $0.7069 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This reading has stood for 2 trading days, since 2026-08-25.
Read from daily closes as of 2026-08-26.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Pulled back from the 12-month high · Broke down to a new 20-day low · MACD just crossed bearish (12/26/9) · trendless / choppy (low ADX) · lagging the market | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-08-26. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$3.06 range $1.25 – $5.00; median $3.00
Analyst estimates, as of 2026-08-24. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for SLQT
- Consensus EPS estimate-$0.135 next reporting period, as of 2026-08-24
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["heavy reliance on a limited number of insurance carrier partners for revenue","significant regulatory oversight in the insurance and pharmacy industries","highly competitive market for insurance lead acquisition and agent talent"]
What changed in the latest 10-Q
AI-assisted comparison of SLQT's 10-Q filed 2026-05-05 against the prior one filed 2026-02-05.
Management's Discussion & Analysis (MD&A)
- Added:
- MA and MS plans accounted for 90% of approved Senior policies for three months ended March 31, 2026 (newer filing, 2026-05-05)
- MA and MS plans accounted for 90% of approved Senior policies for nine months ended March 31, 2026 (newer filing, 2026-05-05)
- Reference to comparison with 2025 periods for three months and nine months ended March 31 (newer filing, 2026-05-05)
- Removed:
- MA and MS plans accounted for 93% of approved Senior policies for three months ended December 31, 2025 (older filing, 2026-02-05)
- MA and MS plans accounted for 93% of approved Senior policies for six months ended December 31, 2025 (older filing, 2026-02-05)
- Reference to comparison with 2024 periods for three months and six months ended December 31 (older filing, 2026-02-05)
- Reworded:
- Period reference changed from 'three months ended December 31, 2025' to 'three months ended March 31, 2026'
- Period reference changed from 'six months ended December 31, 2025' to 'nine months ended March 31, 2026'
- Comparison years changed from 2025 and 2024 to 2026 and 2025
- MA and MS plan percentage changed from 93% to 90% for most recent three-month period
- Notes:
- Both documents appear truncated at the end; comparison is limited to the provided text
- The changes reflect different reporting periods (Q4 2025 year-end in older filing versus Q1 2026 quarter-end in newer filing)
Risk Factors
- Added:
- Newer filing shows table of contents page numbers: Item 1A Risk Factors on page 64, Item 6 Exhibits on page 66, Signatures on page 67 (filed 2026-05-05)
- Newer filing balance sheet dated March 31, 2026 with comparison to June 30, 2025 (filed 2026-05-05)
- Newer filing consolidated statements of comprehensive income for three months and nine months ended March 31, 2026 and 2025 (filed 2026-05-05)
- Newer filing statements of changes in shareholders' equity for three months and nine months ended March 31, 2026 (filed 2026-05-05)
- In newer filing, cash decreased from $35,733 thousand to $35,211 thousand (filed 2026-05-05)
- In newer filing, accounts receivable increased from $151,388 thousand to $234,291 thousand (filed 2026-05-05)
- In newer filing, commissions receivable-current decreased from $132,077 thousand to $76,836 thousand (filed 2026-05-05)
- In newer filing income statement, nine months ended March 31, 2026 shows net income of $79,031 thousand with net income attributable to common shareholders of $24,649 thousand (filed 2026-05-05)
- Removed:
- Older filing shows table of contents page numbers: Item 1A Risk Factors on page 63, Item 6 Exhibits on page 64, Signatures on page 65 (filed 2026-02-05)
- Older filing balance sheet dated December 31, 2025 with comparison to June 30, 2025 (filed 2026-02-05)
- Older filing consolidated statements of comprehensive income for three months and six months ended December 31, 2025 and 2024 (filed 2026-02-05)
- Older filing statements of changes in shareholders' equity for three months and six months ended December 31, 2025 (filed 2026-02-05)
- In older filing income statement, six months ended December 31, 2025 shows net income of $38,834 thousand with net income attributable to common shareholders of $3,227 thousand (filed 2026-02-05)
- Reworded:
- Comparison period in balance sheet changed from December 31, 2025 to March 31, 2026 in newer filing (filed 2026-05-05)
- Income statement period changed from three months and six months ended December 31, 2025 to three months and nine months ended March 31, 2026 in newer filing (filed 2026-05-05)
- Preferred stock liquidation preference increased from $394.2 million at December 31, 2025 to $408.4 million at March 31, 2026 in newer filing (filed 2026-05-05)
- Notes:
- These are different quarterly reporting periods (Q4 2025 year-end filing versus Q1 2026 quarter-end filing) rather than revisions of the same period
- Financial statement line items and values are different due to different reporting dates, not due to restatements or revisions
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days.
- Last 180 days0 buys · 1 sell ($4080) — 1 selling insider
Most recent open-market transaction: 2026-05-19. As of 2026-08-27.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about SLQT's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding SLQT as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 15,575,705
- Reported value $9,804,906
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 4 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
SLQT had 1,563,820 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
SLQT had 0.89% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 1.79 days to cover at the same settlement.
- Reported short interest (shares) 1,563,820
- Short interest (% of shares outstanding) 0.89%
- Prior settlement (shares) 1,607,128
- Reported change -2.69%
- Days to cover (reported) 1.79
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- eHealth (EHTH)
- GoHealth (GOCO)
- Marsh & McLennan (MMC)
- Arthur J. Gallagher (AJG)
- CVS Health (CVS)
- Walgreens Boots Alliance (WBA)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare SLQT vs…
SLQT ranks in…
Frequently asked questions
What does SelectQuote, Inc. (SLQT) do?
SelectQuote operates a digital marketplace that helps individual insurance consumers compare and purchase life, auto, home, and health insurance policies. The company earns commissions from insurance carriers for directing qualified leads and customer enrollments. Additionally, SelectQuote runs a pharmacy business that provides discounted prescription medications and other pharmaceutical products to consumers, generating revenue through direct retail sales and third-party network relationships.
What sector is SelectQuote, Inc. (SLQT) in?
SelectQuote, Inc. (SLQT) is classified in the Financials sector. Its industry is Digital Insurance Marketplace & Distribution. It trades on NYSE.
Who are SelectQuote, Inc.'s (SLQT) competitors?
Notable peers of SelectQuote, Inc. (SLQT) include eHealth, GoHealth, Marsh & McLennan, Arthur J. Gallagher and CVS Health. This peer set is informational only — not financial advice.
Is SelectQuote, Inc. (SLQT) overbought or oversold right now?
SelectQuote, Inc. (SLQT) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 32, in the neutral middle (as of 2026-08-26). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on SLQT come from?
Fundamentals and prices come from market data, as of 2026-08-26; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-26. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-26.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.